Hinge Health (HNGE) Form 4: President holds 804,904 shares

Hinge Health, Inc. (HNGE) reported an insider equity transaction by its President on a Form 4.

Accepted by SEC EDGAR 11/19/2025 - 04:52 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reported an insider equity transaction by its President on a Form 4. On 11/18/2025, the officer had 15,977 shares of Class A common stock withheld and cancelled at a price of $40.84 per share to cover federal and state tax obligations arising from the vesting of restricted stock units, in an exempt transaction under Section 16b-3(e). After this tax-withholding event, the officer beneficially owned 804,904 shares of Class A common stock, which include 781 shares acquired on November 14, 2025 through the company’s employee stock purchase plan.

Insider Trade Summary

Exercise Price or Tax Liability: 15,977 shares

Exercise Price or Tax Liability 1 txn

Insider Pursley James

Role President

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	15,977	$40.84	$653K

Holdings After Transaction: Class A Common Stock — 804,904 shares (Direct)

Footnotes (2)

1. F1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.
2. F2. Includes 781 shares of Class A Common Stock acquired by the Reporting Person on November 14, 2025 pursuant to the Issuer's employee stock purchase plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Hinge Health (HNGE) disclose in this Form 4 filing?

Hinge Health disclosed that its President had 15,977 shares of Class A common stock withheld and cancelled on 11/18/2025 to cover tax obligations related to restricted stock unit vesting, in an exempt Section 16b-3(e) transaction.

How many Hinge Health (HNGE) shares does the reporting officer hold after the transaction?

Following the reported transaction, the officer beneficially owns 804,904 shares of Hinge Health Class A common stock in direct ownership.

What was the price used for the Hinge Health (HNGE) tax-withholding shares?

The 15,977 shares withheld and cancelled to satisfy tax obligations were valued at a price of $40.84 per share.

Was the Hinge Health (HNGE) insider transaction a market sale?

No. The filing states it was an exempt transaction under Section 16b-3(e), in which shares were relinquished and cancelled by the issuer to cover the officer’s tax withholding obligations from restricted stock unit vesting.

Did the Hinge Health (HNGE) officer acquire additional shares recently?

Yes. The reported 804,904 shares beneficially owned include 781 shares of Class A common stock acquired on November 14, 2025 under Hinge Health’s employee stock purchase plan.

What is the role of the reporting person in Hinge Health (HNGE)?

The reporting person is identified as an officer of Hinge Health, holding the title of President, and files individually on this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/18/2025		F(1)		15,977	D	$40.84	804,904(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

2. Includes 781 shares of Class A Common Stock acquired by the Reporting Person on November 14, 2025 pursuant to the Issuer's employee stock purchase plan.

	/s/ David Wood, Attorney-in-Fact	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.